Buprenorphine, a medication used for pain management, carries a risk of serious interactions with other substances such as alcohol, certain medications (including some antibiotics, antidepressants, ...

September 28, 2010 (Las Vegas, Nevada) — A transdermal application system containing the partial μ-opioid receptor agonist buprenorphine showed analgesic efficacy in the treatment of low back pain in ...

STAMFORD, Conn., Sept. 24, 2013 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food and Drug Administration (FDA) approved a new 15 mcg/hour dosage strength of Butrans® (buprenorphine) ...

Purdue Pharma has received the US Food and Drug Administration (FDA) approval for a new 15 mcg/hour dosage strength of Butrans (buprenorphine) Transdermal System CIII, which will provide an additional ...

GREENFIELD, Ind.--(BUSINESS WIRE)--With the U.S. Food and Drug Administration (FDA) approval of Zorbium™ (buprenorphine transdermal solution), Elanco Animal Health (NYSE: ELAN) expands its pain ...

At a PAINWeek 2012 presentation investigators reported that immediate-release opioids are acceptable to use as supplemental analgesia in certain situations, according to the Monthly Prescribing ...

Evidence from a new study to support the safety and pharmacokinetics of Butrans (buprenorphine; Purdue Pharma) transdermal pain patch in children falls short, according to some members of a joint US ...

Teva's Buprenorphine Transdermal System is available in 4 individually-packaged systems per carton in the following strengths: 5mcg/hr, 10mcg/hr, 15mcg/hr, 20mcg/hr. Buprenorphine Transdermal System, ...

ORLANDO, FL / ACCESSWIRE / March 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that ...

FDA issues approval for new, prescription medication to control postoperative pain associated with surgical procedures in cats, expanding Elanco’s pain portfolio. A new long-acting medication to ...